Aeluma is trading 5.3% up at $17.05, extending its recent rally following a Letter of Intent with the U.S. Department of Commerce for CHIPS and Science Act R&D funding.
- Investors are re-pricing the potential impact of up to $30 million in proposed government support on the company's growth trajectory and balance sheet.
- Aeluma is significantly outperforming the broader semiconductor sector, which is currently under pressure due to concerns over AI-related spending.